Laparoscopy in the treatment of cancer of the corpus uteri in patients with metabolic syndrome. A case report

Today, the common term metabolic syndrome encompasses visceral (abdominal) obesity, glucose intolerance, type 2 diabetes mellitus (DM), hypertension, and dyslipidemia. In Europe, the rate of obesity mong the women ranges from 6 to 36 %. In the USA, 65 % of the adult population is overweight and 30 % is obese. High estrogen production in adipose tissue in patients with obesity has been established to increase the risk of cancer of the corpus uteri (CCU) by 4 times as compared to that in normal weight female patients. Furthermore, obese patients are at increased risk for DM that is also a risk factor for CCU. A rise in the number of obese patients leads to the population redistribution of gynecological cancer. The increasing number of patients with gynecological cancer is overweight. This patient group has an increased risk from surgery and anesthesia, a higher incidence of postoperative complications, and delayed recovery. Laparotomy increases the duration of hospital stay and the rate of wound complications. The frequency of urologic injuries in obese patients varies between 2 and 4 %. In this patient category, the rate of damage to the large vessels or bowels has also statistically significant differences. The literature highlights a number of complications specific to patients with obesity: trocar damage to anterior abdominal wall vessels, particularly to the inferior epigastric artery, urinary bladder, as well as trocar site hernia. The authors describe their experience in treating CCU patients with metabolic syndrome at the Department of Surgery for Female Reproductive System Tumors, N. N. Blokhin Russian Cancer Research Center. They demonstrate that laparoscopic extirpation of the uterus and its appendages can be performed in patients with third-degree obesity (weighing 174 kg) in Stage I CCU. It should be noted that this weight was previously regarded as an absolute contraindication to surgical treatment. Today, the active introduction of laparoscopic techniques into gynecological oncology and the improvement of anesthetic maintenance make it possible to virtually level off a contraindication to surgery, such as obesity, and to transfer it to a class of indications. An examination algorithm and the clinical features of the disease are given.

1. Eltabbakh G.H., Shamonki M.I., Moody J.M., Garafano L.L. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy? Gynecol Oncol 2000;78(3 Pt 1):329–35.

2. O’Hanlan K.A., Lopez L., Dibble S.L. et al. Total laparoscopic hysterectomy: body mass index and outcomes. Obstet Gynecol 2003;102(6):1384–92.

3. Obermair A., Manolitsas T.P., Leung Y. et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 2005;15(2):319–24.

4. Weaver J.M. Increased anesthetic risk for patients with obesity and obstructive sleep apnea. Anesth Prog 2004;51(3):75.

5. Everett E., Tamimi H., Greer B. et al. The effect of body mass index on clinical/ pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2003;90(1): 150–7.

6. Manolitsas T.P., McCartney A.J. Total laparoscopic hysterectomy in the management of endometrial carcinoma. J Am Assoc Gynecol Laparosc 2002;9(1): 54–62.

7. Mendoza D., Newman R.C., Albala D. et al. Laparoscopic complications in markedly obese urologic patients (a multi-institutional review). Urology 1996;48(4): 562–7.

8. Modesitt S.C., van Nagell J.R. Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv 2005;60(10): 683–92.

9. Berghofer A., Pischon T., Reinhold T. et al. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008;8:200.

10. Klenk J., Nagel G., Ulmer H. et al. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol 2009;24(2):83–91.

11. Gaglione M.M. Obesity and risk of death. N Engl J Med 2009;360(10):1042; author reply 1043–4.

12. Trentham-Dietz A., Nichols H.B., Hampton J.M., Newcomb P.A. Weight change and risk of endometrial cancer. Int J Epidemiol 2006;35(1):151–8.

13. Goodman M.T., Hankin J.H., Wilkens L.R. et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57(22):5077–85.

14. Pellegrino A., Signorelli M., Fruscio R. et al. Feasibility and morbidity of total laparoscopic radical hysterectomy with or without pelvic limphadenectomy in obese women with stage I endometrial cancer. Arch Gynecol Obstet 2009;279(5):655–60.

15. Eisenhauer E.L., Wypych K.A., Mehrara B.J. et al. Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy. Ann Surg Oncol 2007;14(8):2384–91